Name | Number of supported studies | Average coverage | |
---|---|---|---|
transit amplifying cell | 3 studies | 40% ± 19% |
Insufficient scRNA-seq data for expression of FANCD2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
bladder | 100% | 380.10 | 21 / 21 | 99% | 10.18 | 501 / 504 |
uterus | 100% | 397.85 | 170 / 170 | 99% | 11.18 | 455 / 459 |
breast | 100% | 500.54 | 458 / 459 | 99% | 9.32 | 1104 / 1118 |
ovary | 100% | 580.72 | 180 / 180 | 98% | 7.35 | 422 / 430 |
esophagus | 98% | 466.65 | 1418 / 1445 | 99% | 9.62 | 181 / 183 |
intestine | 99% | 634.98 | 953 / 966 | 98% | 8.97 | 514 / 527 |
lung | 99% | 505.57 | 573 / 578 | 96% | 7.07 | 1108 / 1155 |
skin | 99% | 919.96 | 1791 / 1809 | 95% | 8.62 | 447 / 472 |
stomach | 98% | 390.91 | 351 / 359 | 96% | 8.08 | 274 / 286 |
prostate | 100% | 480.27 | 245 / 245 | 80% | 2.86 | 401 / 502 |
pancreas | 88% | 189.73 | 288 / 328 | 85% | 4.30 | 152 / 178 |
thymus | 99% | 311.36 | 649 / 653 | 70% | 3.22 | 422 / 605 |
brain | 69% | 140.92 | 1812 / 2642 | 63% | 3.81 | 442 / 705 |
kidney | 89% | 266.39 | 79 / 89 | 36% | 1.23 | 327 / 901 |
adrenal gland | 93% | 229.83 | 241 / 258 | 21% | 0.91 | 48 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 18.17 | 29 / 29 |
spleen | 100% | 1608.73 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 13.31 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.62 | 1 / 1 |
adipose | 99% | 365.11 | 1197 / 1204 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 1659.67 | 906 / 929 | 0% | 0 | 0 / 0 |
blood vessel | 85% | 181.87 | 1135 / 1335 | 0% | 0 | 0 / 0 |
liver | 34% | 73.33 | 77 / 226 | 46% | 2.15 | 187 / 406 |
heart | 44% | 71.93 | 380 / 861 | 0% | 0 | 0 / 0 |
muscle | 27% | 43.28 | 215 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 16% | 0.44 | 13 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097150 | Biological process | neuronal stem cell population maintenance |
GO_0036297 | Biological process | interstrand cross-link repair |
GO_0010332 | Biological process | response to gamma radiation |
GO_0007129 | Biological process | homologous chromosome pairing at meiosis |
GO_0007276 | Biological process | gamete generation |
GO_0050727 | Biological process | regulation of inflammatory response |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0045589 | Biological process | regulation of regulatory T cell differentiation |
GO_1990918 | Biological process | double-strand break repair involved in meiotic recombination |
GO_2000348 | Biological process | regulation of CD40 signaling pathway |
GO_0048854 | Biological process | brain morphogenesis |
GO_0031573 | Biological process | mitotic intra-S DNA damage checkpoint signaling |
GO_0005730 | Cellular component | nucleolus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016604 | Cellular component | nuclear body |
GO_0005829 | Cellular component | cytosol |
GO_1990391 | Cellular component | DNA repair complex |
GO_0000793 | Cellular component | condensed chromosome |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0070182 | Molecular function | DNA polymerase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | FANCD2 |
Protein name | FA complementation group D2 Fanconi anemia group D2 protein (Protein FACD2) |
Synonyms | FACD |
Description | FUNCTION: Required for maintenance of chromosomal stability. Promotes accurate and efficient pairing of homologs during meiosis. Involved in the repair of DNA double-strand breaks, both by homologous recombination and single-strand annealing. May participate in S phase and G2 phase checkpoint activation upon DNA damage. Plays a role in preventing breakage and loss of missegregating chromatin at the end of cell division, particularly after replication stress. Required for the targeting, or stabilization, of BLM to non-centromeric abnormal structures induced by replicative stress. Promotes BRCA2/FANCD1 loading onto damaged chromatin. May also be involved in B-cell immunoglobulin isotype switching. . |
Accessions | ENST00000287647.7 [Q9BXW9-1] ENST00000675286.1 [Q9BXW9-2] ENST00000625535.1 ENST00000431693.1 [Q9BXW9-4] A0A6Q8PFY3 ENST00000435522.5 H7BZJ7 Q9BXW9 ENST00000419585.5 [Q9BXW9-2] ENST00000421731.5 ENST00000682647.1 F8WE37 ENST00000676013.1 |